Concepedia

Author

Balakrishna Koneru

Texas Tech UniversityORCID

Also Known As

Balakrishna Koneru

44

Publications

316

Citations

8

H-Index

11

Concepts

All Affiliations

Texas Tech UniversityTexas Tech University Health Sciences CenterGTx (United States)Pediatrics and Genetics
BK

About

Balakrishna Koneru is an author at Texas Tech University specializing in tumor biology, immune surveillance, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

22

2

Cell Biology

1

1

22

3

Pathology

1

1

22

4

Pharmacology

1

1

22

5

Cancer Cell Biology

1

1

22

Balakrishna Koneru

×

7

Publications

281

Citations

7

H-Index

YearCitations

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

Balakrishna Koneru, Gonzalo López, Ahsan Farooqi,

Cancer Research

2020

100

ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156

Balakrishna Koneru, Ahsan Farooqi, Thinh H. Nguyen,

Science Translational Medicine

2021

57

Reactive Oxygen Species–Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies

Monish Ram Makena, Balakrishna Koneru, Thinh H. Nguyen,

Molecular Cancer Therapeutics

2017

50

Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function

Shawn J. Macha, Balakrishna Koneru, Trevor A. Burrow,

Cancer Research

2022

24

Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2–Expressing Neuroblastoma Preclinical Models

Thinh H. Nguyen, Balakrishna Koneru, Sung‐Jen Wei,

Molecular Cancer Therapeutics

2019

22

Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies

Monish Ram Makena, Thinh H. Nguyen, Balakrishna Koneru,

Anti-Cancer Drugs

2020

16

Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia

Michael M. Song, Monish Ram Makena, Ashly Hindle,

Anti-Cancer Drugs

2018

12

Page 1